髄膜炎診断および治療の世界市場予測(~2023年)

【英語タイトル】Global Meningitis Diagnosis and Treatment Market Research Report Forecast to 2023

Market Research Futureが出版した調査資料(MRF9DC121)・商品コード:MRF9DC121
・発行会社(調査会社):Market Research Future
・発行日:2019年6月
・ページ数:164
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(印刷不可、Online Access)USD4,450 ⇒換算¥511,750見積依頼/購入/質問フォーム
Enterprisewide Price(印刷可)USD6,250 ⇒換算¥718,750見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、髄膜炎診断および治療の世界市場について調査・分析し、プロローグ、エグゼクティブサマリー、市場紹介、調査方法、市場動向、市場要因分析、タイプ別(ウイルス性髄膜炎、細菌性髄膜炎、真菌性髄膜炎)分析、治療および診断別(抗生物質、ステロイド、抗真菌薬、1脊椎タップ(腰椎穿刺)、イメージング技術、血液検査)分析、エンドユーザー別(病院および診療所、診断センター)分析、地域別分析、競合分析、会社概要などを含め、以下の構成でお届けします。
・プロローグ
・エグゼクティブサマリー
・市場紹介
・調査方法
・市場動向
・市場要因分析
・髄膜炎診断および治療の世界市場:タイプ別(ウイルス性髄膜炎、細菌性髄膜炎、真菌性髄膜炎)
・髄膜炎診断および治療の世界市場:治療および診断別(抗生物質、ステロイド、抗真菌薬、1脊椎タップ(腰椎穿刺)、イメージング技術、血液検査)
・髄膜炎診断および治療の世界市場:エンドユーザー別(病院および診療所、診断センター)
・髄膜炎診断および治療の世界市場:地域別分析
・競合分析
・会社概要
【レポートの概要】

Global Meningitis Diagnosis and Treatment Market Research Report: by Type (Viral Meningitis, Bacterial Meningitis, and Others), by Treatment & Diagnosis (Treatment and Diagnosis), by End-user (Hospitals & Clinics, Others), and Region – Forecast till 2023
Market analysis

The Global Meningitis Diagnosis and Treatment Market is relied upon to ascend to a valuation of USD 430.2 million by 2023, ascending at a strong 3.38% CAGR over the conjecture time frame from 2018 to 2023. The global meningitis diagnosis and treatment market is for the most part determined by the developing predominance of meningitis just as the expanding endeavors to battle the infection, including endeavors to diminish the rate of the illness just as endeavors to deal with the ailment better. The developing extent of the human services segment in rising areas is probably going to be a noteworthy driver for the global meningitis diagnosis and treatment market over the conjecture time frame. The growing prevalence of bacterial and viral meningitis is likely to be a major factor for the growth of global meningitis diagnosis and treatment market during the forecast period (2017- 2023).

Market segmentation

The global meningitis diagnosis and treatment market is segmented on the basis of service, end user, disease type, and regional demand. On the basis of its disease type, the global meningitis diagnosis and treatment market is bifurcated into viral meningitis, bacterial meningitis, fungal meningitis, and others. Based on its service, the global meningitis diagnosis and treatment market is categorized into diagnosis and treatment. On the basis of its end user, the global meningitis diagnosis and treatment market is classified into diagnostic centers, hospitals & clinics, and others.

Regional demand

Geographically, the global meningitis diagnosis and treatment market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major players

Thermo Fisher Scientific Inc., Quest Diagnostics Inc., Luminex Corporation, F. Hoffman-La Roche Ltd., Cepheid, and Pfizer Inc., B. Braun Melsungen AG, Sanofi, Pfizer Inc., Siemens Healthcare Private Limited, GlaxoSmithKline plc, Merck KGaA, Baxter, Abbott, Bio-Rad Laboratories Inc., among others are some of the major players in the global meningitis diagnosis and treatment market.

【レポートの目次】

Table of Contents:

1 Report Prologue
2 Executive Summary
3 Market Introduction
3.1 Definition
3.2 Scope of the Study
3.3 Assumptions & Limitations
3.3.1 Assumptions
3.3.2 Limitations
3.4 Market Structure
4 Research Methodology
4.1 Research Process
4.2 Primary Research
4.3 Secondary Research
4.4 Market Size Estimation
4.5 Forecast Model
5 Market Dynamics
5.1 Introduction
5.2 Drivers
5.2.1 Large Patient Population
5.2.2 Increasing Prevalence of Bacterial, Viral, and Fungal Infections
5.2.3 Rising Demand for Point of Care Diagnostic Services for Chronic Diseases
5.3 Restraints
5.3.1 Side-Effects of Antibiotics and Steroids
5.3.2 Lack of Awareness About Meningitis
5.4 Opportunities
5.4.1 Research for the Development of Specific Drugs for the Treatment of Meningitis
5.5 Technology Trends and Assessment
5.5.1 Increasing Focus on Combination Therapies
6 Market Factor Analysis
6.1.1 R&D and Designing
6.1.2 Manufacturing
6.1.3 Distribution & Sales
6.1.4 Post-Sales Monitoring
6.2 Porter’s Five Forces Model
6.2.1 Bargaining Power of Suppliers
6.2.2 Bargaining Power of Buyers
6.2.3 Threat of New Entrants
6.2.4 Threat of Substitutes
6.2.5 Intense Rivalry
6.3 Investment Opportunity Analysis
6.3.1 Market size (current and future), growth rate, and profitability
6.3.2 Investment Risks
6.3.3 Market Outlook
6.3.4 Competitors
6.3.5 Projections
6.4 Meningitis Tests (Number of tests for the Europe region)
7 Global Meningitis Diagnosis and Treatment Market, by Type
7.1 Introduction
7.2 Viral Meningitis
7.3 Bacterial Meningitis
7.4 Fungal Meningitis
8 Global Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis
8.1 Introduction
8.2 Treatment
8.2.1 Antibiotics
8.2.2 Steroids
8.2.3 Antifungal Drugs
8.3 Diagnosis
8.3.1 Spinal Tap (Lumbar Puncture)
8.3.2 Imaging Techniques
8.3.3 Blood Tests
9 Global Meningitis Diagnosis and Treatment Market, by End User
9.1 Introduction
9.2 Hospitals & Clinics
9.3 Diagnostic Centers
10 Global Meningitis Diagnosis and Treatment Market, by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 US
10.2.1.2 Canada
10.2.2 Latin America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 UK
10.3.1.2 France
10.3.1.3 Germany
10.3.1.4 Spain
10.3.1.5 Italy
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia-Pacific
10.5 Middle East & Africa
10.5.1 Middle East
10.5.2 Africa
11 Competitive Landscape
11.1 Introduction
11.2 Company Market Share Analysis
12 Company Profiles
12.1 B. Braun Melsungen AG
12.1.1 Company Overview
12.1.2 Financial Overview
12.1.3 Products/Services Offered
12.1.4 Key Developments
12.1.5 SWOT Analysis
12.1.6 Key Strategy
12.2 Sanofi
12.2.1 Company Overview
12.2.2 Financial Overview
12.2.3 Products/Services Offered
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.2.6 Key Strategy
12.3 Pfizer Inc.
12.3.1 Company Overview
12.3.2 Financial Overview
12.3.3 Products/Services Offered
12.3.4 Key Developments
12.3.5 SWOT Analysis
12.3.6 Key Strategy
12.4 Siemens Healthcare Private Limited
12.4.1 Company Overview
12.4.2 Financial Overview
12.4.3 Products/Services Offered
12.4.4 Key Developments
12.4.5 SWOT Analysis
12.4.6 Key Strategy
12.5 GlaxoSmithKline Plc.
12.5.1 Company Overview
12.5.2 Financial Overview
12.5.3 Products/Services Offered
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.5.6 Key Strategy
12.6 Merck KGaA
12.6.1 Company Overview
12.6.2 Financial Overview
12.6.3 Products/Services Offered
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.6.6 Key Strategy
12.7 Baxter
12.7.1 Company Overview
12.7.2 Financial Overview
12.7.3 Products/Services Offered
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.7.6 Key Strategy
12.8 Abbott
12.8.1 Company Overview
12.8.2 Financial Overview
12.8.3 Products/Services Offered
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.8.6 Key Strategy
12.9 Bio-Rad Laboratories Inc.
12.9.1 Company Overview
12.9.2 Financial Overview
12.9.3 Products/Services Offered
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.9.6 Key Strategy
12.1 Thermo Fisher Scientific Inc.
12.10.1 Company Overview
12.10.2 Financial Overview
12.10.3 Products/Services Offered
12.10.4 Key Developments
12.10.5 SWOT Analysis
12.10.6 Key Strategy
12.11 Quest Diagnostics Incorporated
12.11.1 Company Overview
12.11.2 Financial Overview
12.11.3 Products/Services Offered
12.11.4 Key Developments
12.11.5 SWOT Analysis
12.11.6 Key Strategy
12.12 Luminex Corporation
12.12.1 Company Overview
12.12.2 Financial Overview
12.12.3 Products/Services Offered
12.12.4 Key Developments
12.12.5 SWOT Analysis
12.12.6 Key Strategy
12.13 F. Hoffmann-La Roche Ltd
12.13.1 Company Overview
12.13.2 Financial Overview
12.13.3 Products/Services Offered
12.13.4 Key Developments
12.13.5 SWOT Analysis
12.13.6 Key Strategy
12.14 Cepheid
12.14.1 Company Overview
12.14.2 Financial Overview
12.14.3 Products/Services Offered
12.14.4 Key Developments
12.14.5 SWOT Analysis
12.14.6 Key Strategy
13 Appendix
13.1 Discussion Blue Print

List of Tables:

TABLE 1 MARKET SYNOPSIS
TABLE 2 PRIMARY INTERVIEWS
TABLE 3 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 4 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR VIRAL MENINGITIS, BY REGION, 2015–2023 (USD MILLION)
TABLE 5 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR BACTERIAL MENINGITIS, BY REGION, 2015–2023 (USD MILLION)
TABLE 6 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR FUNGAL MENINGITIS, BY REGION, 2015–2023 (USD MILLION)
TABLE 7 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION)
TABLE 8 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION)
TABLE 9 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION)
TABLE 10 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR TREATMENT, BY REGION, 2015–2023 (USD MILLION)
TABLE 11 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR ANTIBIOTICS, BY REGION, 2015–2023 (USD MILLION)
TABLE 12 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR STEROIDS, BY REGION, 2015–2023 (USD MILLION)
TABLE 13 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR ANTIFUNGAL DRUGS, BY REGION, 2015–2023 (USD MILLION)
TABLE 14 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR DIAGNOSIS, BY REGION, 2015–2023 (USD MILLION)
TABLE 15 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR SPINAL TAP (LUMBAR PUNCTURE), BY REGION, 2015–2023 (USD MILLION)
TABLE 16 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR IMAGING TECHNIQUES, BY REGION, 2015–2023 (USD MILLION)
TABLE 17 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR BLOOD TESTS, BY REGION, 2015–2023 (USD MILLION)
TABLE 18 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 19 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR HOSPITALS & CLINICS, BY REGION, 2015–2023 (USD MILLION)
TABLE 20 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2015–2023 (USD MILLION)
TABLE 21 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY REGION, 2015–2023 (USD MILLION)
TABLE 22 AMERICAS: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY REGION, 2015–2023 (USD MILLION)
TABLE 23 AMERICAS: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 24 AMERICAS: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION)
TABLE 25 AMERICAS: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION)
TABLE 26 AMERICAS: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION)
TABLE 27 AMERICAS: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 28 NORTH AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY COUNTRY, 2015–2023 (USD MILLION)
TABLE 29 NORTH AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 30 NORTH AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION)
TABLE 31 NORTH AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION)
TABLE 32 NORTH AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION)
TABLE 33 NORTH AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 34 US: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 35 US: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION)
TABLE 36 US: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION)
TABLE 37 US: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION)
TABLE 38 US: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 39 CANADA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 40 CANADA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION)
TABLE 41 CANADA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION)
TABLE 42 CANADA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION)
TABLE 43 CANADA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 44 LATIN AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 45 LATIN AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION)
TABLE 46 LATIN AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION)
TABLE 47 LATIN AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION)
TABLE 48 LATIN AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 49 EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY REGION, 2015–2023 (USD MILLION)
TABLE 50 EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 51 EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION)
TABLE 52 EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION)
TABLE 53 EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION)
TABLE 54 EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 55 WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY COUNTRY, 2015–2023 (USD MILLION)
TABLE 56 WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 57 WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION)
TABLE 58 WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION)
TABLE 59 WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION)
TABLE 60 WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 61 UK: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 62 UK: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION)
TABLE 63 UK: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION)
TABLE 64 UK: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION)
TABLE 65 UK: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 66 FRANCE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 67 FRANCE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION)
TABLE 68 FRANCE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION)
TABLE 69 FRANCE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION)
TABLE 70 FRANCE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 71 GERMANY: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 72 GERMANY: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION)
TABLE 73 GERMANY: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION)
TABLE 74 GERMANY: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION)
TABLE 75 GERMANY: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 76 SPAIN: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 77 SPAIN: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION)
TABLE 78 SPAIN: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION)
TABLE 79 SPAIN: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION)
TABLE 80 SPAIN: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 81 ITALY: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 82 ITALY: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION)
TABLE 83 ITALY: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION)
TABLE 84 ITALY: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION)
TABLE 85 ITALY: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 86 REST OF WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 87 REST OF WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION)
TABLE 88 REST OF WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION)
TABLE 89 REST OF WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION)
TABLE 90 REST OF WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 91 EASTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 92 EASTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION)
TABLE 93 EASTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION)
TABLE 94 EASTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION)
TABLE 95 EASTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 96 ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY COUNTRY, 2015–2023 (USD MILLION)
TABLE 97 ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 98 ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION)
TABLE 99 ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION)
TABLE 100 ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION)
TABLE 101 ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 102 CHINA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 103 CHINA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION)
TABLE 104 CHINA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION)
TABLE 105 CHINA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION)
TABLE 106 CHINA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 107 JAPAN: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 108 JAPAN: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION)
TABLE 109 JAPAN: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION)
TABLE 110 JAPAN: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION)
TABLE 111 JAPAN: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 112 INDIA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 113 INDIA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION)
TABLE 114 INDIA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION)
TABLE 115 INDIA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION)
TABLE 116 INDIA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 117 AUSTRALIA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 118 AUSTRALIA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION)
TABLE 119 AUSTRALIA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION)
TABLE 120 AUSTRALIA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION)
TABLE 121 AUSTRALIA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 122 SOUTH KOREA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 123 SOUTH KOREA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION)
TABLE 124 SOUTH KOREA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION)
TABLE 125 SOUTH KOREA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION)
TABLE 126 SOUTH KOREA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 127 REST OF ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 128 REST OF ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION)
TABLE 129 REST OF ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION)
TABLE 130 REST OF ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION)
TABLE 131 REST OF ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 132 MIDDLE EAST & AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY REGION, 2015–2023 (USD MILLION)
TABLE 133 MIDDLE EAST & AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 134 MIDDLE EAST & AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION)
TABLE 135 MIDDLE EAST & AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION)
TABLE 136 MIDDLE EAST & AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION)
TABLE 137 MIDDLE EAST & AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 138 MIDDLE EAST: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 139 MIDDLE EAST: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION)
TABLE 140 MIDDLE EAST: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION)
TABLE 141 MIDDLE EAST: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION)
TABLE 142 MIDDLE EAST: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 143 AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 144 AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION)
TABLE 145 AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION)
TABLE 146 AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE 2015–2023, (USD MILLION)
TABLE 147 AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION)

List of Figures:

FIGURE 1 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET: MARKET STRUCTURE
FIGURE 2 RESEARCH PROCESS
FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH
FIGURE 4 SUPPLY CHAIN: GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET
FIGURE 5 PORTER’S FIVE FORCES ANALYSIS: GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET
FIGURE 6 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET SHARE, BY TYPE, 2017(%)
FIGURE 7 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2017 & 2023 (USD MILLION)
FIGURE 8 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET SHARE, BY TREATMENT & DIAGNOSIS, 2017 (%)
FIGURE 9 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2017 & 2023 (USD MILLION)
FIGURE 10 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET SHARE, BY END USER, 2017(%)
FIGURE 11 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2017 & 2023 (USD MILLION)
FIGURE 12 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET SHARE, BY REGION, 2017(%)
FIGURE 13 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY REGION, 2017 & 2023 (USD MILLION)
FIGURE 14 AMERICAS: MENINGITIS DIAGNOSIS AND TREATMENT MARKET SHARE, BY REGION, 2017 (%)
FIGURE 15 EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET SHARE, BY REGION, 2017 (%)
FIGURE 16 ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET SHARE, BY COUNTRY, 2017 (%)
FIGURE 17 MIDDLE EAST & AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET SHARE, BY REGION, 2017 (%)
FIGURE 18 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, COMPANY MARKET SHARE ANALYSIS, 2017 (%)

【掲載企業】

Thermo Fisher Scientific Inc., Quest Diagnostics Inc., Luminex Corporation, F. Hoffman-La Roche Ltd., Cepheid, and Pfizer Inc., B. Braun Melsungen AG, Sanofi, Pfizer Inc., Siemens Healthcare Private Limited, GlaxoSmithKline plc, Merck KGaA, Baxter, Abbott, Bio-Rad Laboratories Inc.

★調査レポート[髄膜炎診断および治療の世界市場予測(~2023年)] (コード:MRF9DC121)販売に関する免責事項を必ずご確認ください。
★調査レポート[髄膜炎診断および治療の世界市場予測(~2023年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆